Register For Our Mailing List

Register to receive our free weekly newsletter including editorials.

Home / 601

16 ASX stocks to buy and hold forever, updated

One of my most popular articles from last year was one entitled 16 ASX stocks to buy and hold forever. I think it sparked interest for a few reasons. First, owning stocks that can compound returns at a high rate is an attractive proposition. Second, a number of investors have very long timeframes and there isn’t much in the financial press that caters to these investors.

One year on, I thought it’d be worth revisiting the article to answer the many questions I’ve got from readers since that time, including what stocks on the list may be worth buying now and whether I’d make any changes to the list.

The 16 stocks I chose

Let’s quickly recap the premise of the original article. I got the idea from Warren Buffett, who had famously named several stocks that he’d like his company, Berkshire Hathway, to own forever, including Coca-Cola, American Express, Occidental Petroleum, and the Japanese trading companies.

I thought I could take that and apply it to the local share market. It wasn’t an easy task because I had to be confident that the companies could last indefinitely, and that they had enough growth opportunities to allow them to achieve shareholder returns that beat the ASX 300 index (otherwise, why own them?).

To help with the task, I created seven criteria to identify the ASX stocks that could be held indefinitely:

  1. Part of the ASX 300
  2. Long runway of growth opportunities
  3. Economic moats
  4. Good returns on capital
  5. Sound balance sheets
  6. Don’t rely on exceptional managers to succeed
  7. Unlikely to be disrupted

From these criteria, I chose 16 stocks that you could hold forever:


Source: Morningstar, Firstlinks

To be clear, the list wasn’t a case of buying now and holding forever. It was a wish list of potential stocks to own in future and own indefinitely.

Are there really forever stocks?

One query I got was what I meant by ‘forever’. In a follow-up interview I did with Morningstar’s Mark LaMonica, I clarified that my timeframe for forever was 50+ years.

I also got scepticism about whether any stocks really could be held indefinitely. After all, studies show the average lifespan of an S&P 500 company is around 15 years. The scepticism has merit, though it doesn’t preclude finding special companies that can buck that trend.

One year on, would I change the list?

Yes, I would. In hindsight, there are two weak links in the list. The first is Argo Investments. Put simply, its portfolio returns are continuing to disappoint. I thought it might be a temporary blip, but it has been underperforming for a long period, and there doesn’t seem to be any turnaround to that. My error was that I got caught up in its long history, stable management, and decent returns over almost 80 years. However, as a fund manager, it’s performance that matters, and on that front, its ‘glory days’ appear to be behind it. Consequently, I would eliminate this one from the list.

Some investors have also questioned the merits of Australian Foundation Investment given its recent underperformance. I’ve got more faith that management will turn it around and deliver outperformance in future.

The other stock I have on my watchlist is Aurizon. When I featured it in the list, I said that I love the railroad business. Railroads have cost advantages for bulk transportation that won’t go away. And there are long-term contracts with imbedded price increases. And though Aurizon gets 80% of its earnings from coal haulage, I’m more optimistic than most on coal volumes over the next decade, plus I’m buoyed also by the company’s gradual transition to non-coal transportation.

One thing I may have underestimated is the competition in the industry. That impacts both rate and volumes.

I’m keeping a close eye on this, but for now, I think Aurizon should remain on the list.

The other company that may raise eyebrows is SkyCity. It’s had a horror run, with regulatory crackdowns, a New Zealand economy that’s been in recession, and a broader casino industry that’s been on the nose.

Yet, I’m still a believer in the long-term future of the company given its long-dated and exclusive licences in Auckland and Adelaide. It remains a keeper.

In saying that, the biggest lesson that I’ve learned over the past 12 months is that sometimes the biggest competitive advantage for a company can also be its largest risk. That’s especially the case for companies that have government licences and contracts.

For SkyCity, its economic moat comes from its exclusive casino licences. But we’ve seen increased regulatory scrutiny in New Zealand of late. And in Australia, Crown and Star have encountered the wrath of Governments after decades of friendly regulatory oversight.

We’ve also seen that with another stock on the list: Transurban. Pressure continues for it to renegotiate toll road contracts after a review recommending as such. This is another one to keep a close watch on, though I remain confident that any change to contracts will be adequately compensated and that there are still ample growth opportunities ahead for the company.

What other stocks could be considered for the list?

There are four stocks that were unlucky not to make the original list:

  1. Brambles (ASX: BXB). Wooden pallets are an old technology but it doesn’t look like being replaced any time soon. Brambles is a leader in the industry, operating in 60 countries. Demand for its products should continue to grow given most of its business comes from fast-moving consumer goods.
  2. ARB (ASX: ARB). This company has grown from a local bull bar manufacturer to become a global automotive accessory leader. It’s accelerating its push into the US, recently increasing its stake in Off Road Warehouse, the largest 4x4 accessory retailer in America. Lots of growth opportunities, great returns on capital, and a proven management team make ARB a potential keeper for the long-term.
  3. Goodman Group (ASX: GMG). Greg Goodman is a smart guy who knows how to scale a business and make a buck (or billions of bucks). His pivot into data centres seems well timed and should pay off given the increasing commoditisation of AI should drive greater demand for AI and data centres. Meanwhile, the industrial property business remains well-placed given the rise and rise of e-commerce.
  4. Aristocrat Leisure (ASX: ALL). Aristocrat’s gaming machine business operates in a mature industry but with licencing requirements that limit new players coming into the market. In recent years, it’s expanded into the fast-growing mobile gaming market. This move should drive growth for the company, which has become one of Australia’s biggest overseas success stories.

I mentioned above that I would eliminate Argo from the list of stocks to own forever. In its place, I would choose either Brambles or ARB.

What stocks on the list are worth buying now?

There are six ‘forever’ stocks that I believe are potentially worth buying now:

  • ASX Ltd
  • Aurizon
  • SkyCity
  • Medibank Private
  • The Lottery Corporation
  • Washington H Soul Pattinson

The top three stocks here have all encountered what I consider temporary setbacks. I wrote of Aurizon and SkyCity above. On ASX, it has proven my point in the original article that you want to own companies that don’t rely on exceptional managers to succeed. Because leaders of ASX have failed at a lot of things, and yet the quality of the company is undiminished. Of all the companies, ASX Ltd is my strongest buy idea.

The remaining three companies that I think are potential buys are high quality businesses offering reasonable value. Medibank Private continues to show its strength in an industry that should continue to grow for decades to come. The Lottery Corporation is a great company. Yes, it has regulatory licences, though it seems highly unlikely that Governments will undermine the company’s monopolies in markets. Washington H Soul Pattinson is a proven, canny investor. One wonders if Perpetual or parts of it may be in play for Soul Patts at some stage.

Which of the stocks are overvalued now?

Of the 16 stocks on the list, which are the ones to avoid right now? I would name three:

  • REA
  • Cochlear
  • Wesfarmers

All three companies are high quality, and all are priced for perfection, and beyond.

I considered REA incredibly expensive at this time last year, and the stock is up 33% since! It’s now trading at 18x sales and 53x earnings. The move by Costar on REA rival, Domain, may be the catalyst for a reality check in the REA share price. CoStar is a proven operator with deep pockets and investors may soon fret about the potential implications for REA.

Cochlear’s share price has taken a hit over the past 12 months, yet at 46x earnings, it still seems very overpriced. I think the company can grow profits by high single digits over the next few decades, but there’s no way I’d pay a 46x multiple for that.

Wesfarmers is another that seems overpriced. Again, though, I thought the same thing last year, and it’s performed ok since.

 

James Gruber is Editor of Firstlinks.

 

30 Comments
PJ
March 21, 2025

I can see why you'd include AFIC in your list. However, looking at you criteria list, Point number 7; Unlikely to be disrupted.

The burgeoning popularity of ETF's is a glaringly obvious and therefore must been seen as 'disruptive'. This then rules out criteria number 3; "Economic moats".

I'd also bring into question some of the other criteria and how they would apply to AFIC.

If I were a first time investor, there's no possible way that I would recommend AFIC.

Sabina
March 17, 2025

A CPAP machine is an unwieldy and imperfect solution to the problem of sleep apnea. And the machines are expensive with costly consumables (masks). Many patients don't tolerate CPAP and give up or use it for only a few hours a night. I see GLPs as a more effective solution and I do think they'll impact RMD's long term profits.

James
March 17, 2025

Good

Martin
April 07, 2025

Resmed has actually found quite the opposite: those using GLPs actually have a higher uptake of CPAP therapy.

David
March 13, 2025

If you liked Soul Patts last year or yesterday, you'll love it today: back down to 12 month lows (c.$32). H1 results due out next week I think.

I am perplexed by ASX SOL that it has really gone sideways over the last 4 years. NTA and div are both growing. Maybe it got out beyond its skis a few years ago?

James Gruber
March 17, 2025

David,

Share price maybe got ahead of itself is the logical explanation.

But if NTA and divs are growing ok, the share price will eventually reflect that.

James

x
March 12, 2025

What is it about AFIC's management that gives you hope for outperformance?

James Gruber
March 17, 2025

Hi X,

Decent track record and the current positioning of its portfolio.

James

Stu
March 10, 2025

Totally off the radar but one to watch going forward CVL , with defence having to ramp up they are well positioned to take advantage + you have the big 4 mining companies and WA Gov using them as preferred contractors for new and existing projects.

Trevor
March 11, 2025

Hi Stu, the market didn’t like their latest results announcement. Any idea what’s going on there?

Stu
March 12, 2025

Hi Trevor
I can only guess its because of the self prediction of slowdown in the back half of the year due to project delays by owners at their end [a lot can change before then hopefully] .currently I like their Heads of Agreement for Ownership Transfer of Luerssen - who if you don't know were awarded the patrol boat contract by the fed gov with CVL doing the build and delivery to Luerssen in Adelaide who then added all the fittings and electronics for completion and delivery. CVL did their part on time and on budget but Luerssen could not get their part completed and on budget for delivery .So the Fed Gov cancelled the remaining contract with Luerssen --who now want to get out completely -Aust included. Now this is where it gets interesting, CVL want to take over the remaining contract of I believe 1/last patrol boat still to deliver and also get in the process the waterfront wharf and shed for the project in Adelaide giving them a foot in the door in SA , which if you do your DD is the only state not covered by CVL and their sheds. CVL are gunning for the military contracts [excuse the pun] if you look at the last 2 years and what they have built/bought/acquired -the shed alone in WA has a closed door allowing nobody to see inside. I know I'm rambling now but I'm in and happy to hold.

DR
March 09, 2025

CSL is the share that “those in the know” keep recommending year in and year out with the usual prediction of $320 in recent times .

Over the past 5 years it is down 18 % and a pitiful DY 1,5%

Versus cash at 5% compounded for 5 years is a
27,7 % with essentially no risk

That’s a 45% difference in return. I am aware there may be tax payable depending on circumstances and I haven’t taken CSL DY ( no guarantees) into consideration , but you get my drift .





Michael
March 08, 2025

I already owned AZJ when you wrote last year. I bought in dribs & drabs after it purchased a competitor, thinking it will turn around. Last year looked promising, with dividends having started to rise.
I sold last month. Decreased dividend again. No business improvement. New large contracts operating at a loss with no profit in sight. Totally off my list.

Two on my list :
DBI is doing very well.
I suspect APA is worth a punt at this time.

Tata
March 07, 2025

If buying and holding for 50+ years, why worry about the short-termism of Argo's (and other old school LICs) recent performance /discounts to NTA. If you focus on the income they produce and not the short-term price fluctuations you can argue its a great time to buy and hold forever. Getting the same dividend stream for a discount. Much safer than some of the single stock suggestions made. Doesn't sound like long-term thinking is being applied.

James Gruber
March 07, 2025

Hi Tata,

Long term thinking is being applied here. That's because investment performance will determine the amount of future dividends to will get to shareholders. So, Argo's poor performance over the past decade has resulted in dividends per share increased from 29.5c in 2015 to 34.5c in 2024. That's a compound annual growth rate of 1.6%. That's really poor. I want dividends growing a lot more than that from an LIC.

And I'm not sure the investment performance will improve from here.

What you don't want is continued long-term investment underperformance because that will continue to lead to mediocre dividend growth. You're much better off investing elsewhere, if that's the case.

James

Tata
March 09, 2025

Argo had grown its dividends by 4.4% per annum over the 20yrs from 1997 to 2017. Not too shabby and you can always pick a decade to match individual bias. Argo has always had a value tilt and may hold it in good stead over the next decade being underweight the banks/tech etc Past performance isn't and indicator of.......

James Gruber
March 09, 2025

Tata,

That dividend growth is ok but note that the ASX 300 accumulation index increased by 7.95% over the past 20yrs. So the yield growth trailed the index growth. Argo doesn't make it easy to find 20yr NAV returns for its LIC but I'm guessing its total returns have trailed the index over that time period too.

I agree value could make a comeback, but I'd back Afic more to capture that over Argo. And, Argo is really competing against index ETFs, and I'd struggle to recommend Argo over an broad market ETF.

James

John Collins
March 07, 2025

why would you take a punt of individual stocks on ASX when you can buy Vanguard VAS etf for a very marginal cost.

Derek D
March 06, 2025

There was an excellent article by Greg Canavan (Fat Tail Investment Research) titled, 'Are you really a long-term investor'. The research suggests the average holding period for US Equities has reduced from 5 years to as low as 10 months on average. It notes that the trend over decades has been towards more trading and less buy-to-hold investing. A buy-to-hold or long-term strategy is seemingly now out of favour. I believe it was Buffett who was quoted to have declared, "The stock market is a device for transferring money from the impatient to the patient".

Anthony Gross
March 06, 2025

Hi James,
I suggest you have slightly mis-characterised Warren Buffet's words. For example, over the last 12 months, WB has sold part of his holdings in Apple and Bank of America. Both of which I thought he described as permanent holdings. As well as various questions in AGM he has expressed regret (my word) or similar thoughts at not reducing his stake in Coke when it was trading at P/E's of 30 to 40.

Apart from this, I think the thrust of your article is good.

As well the holding time from retail investors on the NYSE has fallen from 2 years to 7 months. This data may be out of date. But your thoughts on a longer investment time frame is a good warning against over-trading.

James Gruber
March 06, 2025

Hi Anthony,

Buffett never named Apple and Bank of America as stocks he'd like Berkshire to own forever. His comments on Coke were more recently on being a forever stock, though earlier, you are right, he did regret not selling it.

I've noted in previous articles that the silence on Apple being a forever stock was perhaps a clue to his subsequent actions (to sell down).

James

GB
March 06, 2025

Wow. You certainly love the betting companies. What alternatives do you suggest for those who have grave misgivings supporting such a parasitic industry?

James Gruber
March 06, 2025

Hi GB,

Four possible inclusions are mentioned in the article (three non-gaming). 

James

James Gruber
March 06, 2025

Hi CC,

They are possiblities. However, I think CSL is suffering somewhat from the tyranny of size, and I wrote about that here: https://www.firstlinks.com.au/welcome-firstlinks-edition-577

As for Resmed, I am more wary than consenus when it comes to the impact of GLPs on the business. The jury is still out.

James

CC
March 06, 2025

GLPs are very overrated, very expensive, cause lots of unpleasant side effects and many people with OSA are not obese anyway.
Anecdotally the drugs have been beneficial for RMD as its brought more awareness of OSA as an issue, and their EPS have continued growing regardless of the GLPs just as RMD has done consistently for the past 20 years. Arguably the most consistent long term EPS grower on the ASX .

James Gruber
March 06, 2025

Hi CC,

I think GLPs will get much cheaper and better, quickly, and that will test the market more. Let's see.

James

Ian Nettle
March 06, 2025

All good points CC. I know a number of people using these drugs and they all downplay the side effects (to the extent....what side effects?). All they talk about is the energy they have found. Overall, when I look at the size of my fellow Australian's it leaves me in despair.

Investing I have sold out of RMD for the first time ever and I am invested in NVO and LLY and a smaller holding in Amgen all in the US. I would rather see people eat less and exercise more but I observe that it must be just too hard?

Ross
March 09, 2025

CC,

Yes, GLPs are so ineffective that Eli Lily is on track for annualised sales from its obesity drugs of US$20bn and Novo Nordisk did $25bn in sales of these drugs last yr. And the sales are growing expediently.

The impact on the likes of Resmed is likely just delayed.

Don't believe anecdotes and what Resmed bulls tell you. Watch what the companies who are making the drugs are doing and how that evolves.

Ross

Rob Beer
March 11, 2025

It's useful to think about the problem patients are presented with and the difference between the two solutions under consideration.
The doctor is telling the patients they have life threatening sleep apnea and they could suffocate in their sleep. We're talking about death here. It could happen tonight. They are made to feel lucky to have lived this long.
A CPAP machine is a solution they are told will stop that happening, *immediately*, tonight and every night going forward.
If (if!) they are overweight the doctor will tell them that losing weight (however they achieve that) will *reduce the chance* of suffocating in their sleep.
Happily I don't suffer from sleep apnea and I'm not overweight, but if I did I'd *definitely* buy a CPAP machine immediately and after that *maybe* think about trying to lose some weight. Losing weight is hard, so yeah, I think I'd go for GLP's if I could afford them, but only after I'd bought the CPAP machine.

CC
March 06, 2025

CSL and Resmed ?

 

Leave a Comment:

RELATED ARTICLES

16 ASX stocks to buy and hold forever

11 ASX dividend stocks for the next decade

Why August company reporting season was poor

banner

Most viewed in recent weeks

16 ASX stocks to buy and hold forever, updated

This time last year, I highlighted 16 ASX stocks that investors could own indefinitely. One year on, I look at whether there should be any changes to the list of stocks as well as which companies are worth buying now. 

2025-26 super thresholds – key changes and implications

The ABS recently released figures which are used to determine key superannuation rates and thresholds that will apply from 1 July 2025. This outlines the rates and thresholds that are changing and those that aren’t.  

Is Gen X ready for retirement?

With the arrival of the new year, the first members of ‘Generation X’ turned 60, marking the start of the MTV generation’s collective journey towards retirement. Are Gen Xers and our retirement system ready for the transition?

Why the $5.4 trillion wealth transfer is a generational tragedy

The intergenerational wealth transfer, largely driven by a housing boom, exacerbates economic inequality, stifles productivity, and impedes social mobility. Solutions lie in addressing the housing problem, not taxing wealth.

The 2025 Australian Federal election – implications for investors

With an election due by 17 May, we are effectively in campaign mode with the Government announcing numerous spending promises since January and the Coalition often matching them. Here's what the election means for investors.

What Warren Buffett isn’t saying speaks volumes

Warren Buffett's annual shareholder letter has been fixture for avid investors for decades. In his latest letter, Buffett is reticent on many key topics, but his actions rather than words are sending clear signals to investors.

Latest Updates

World's largest asset manager wants to revolutionise your portfolio

Larry Fink is one of the smartest people in the finance industry. In his latest shareholder letter, the Blackrock CEO outlines his quest to become the biggest player in private assets and upend investor portfolios.

Economy

Australia's economic report card heading into the polls

Our economy grew by a nominal rate of 7% per annum from 2017 to 2024, but it benefited from the largesse of fiscal and monetary policies, both of which are now fading. We need a new, credible economic growth agenda.

Preference votes matter

If the recent polls are anything to go by, we are headed for a hung parliament at the upcoming federal election. So more than ever, Australians need to give serious consideration to their preference votes.

SMSF strategies

Meg on SMSFs: Tips for the last member standing

It’s common for people as they age to seek more help in running their SMSF if their capacity declines. An alternate director may be a great solution for someone just planning for short-term help in the meantime.

Wilson Asset Management on markets and its new income fund

In this interview, Matthew Haupt from Wilson Asset Management discusses his outloook for the ASX, sectors such as REITs that he likes, and his firm's launch of a new income-oriented listed investment company.  

Planning

‘Life expectancy’ – and why I don’t like the expression

Life expectancy isn't just a number - it's a concept that changes with survival rates over time. This article breaks down how age, survival, and societal factors shape our understanding of life expectancy, especially post-Covid. 

The shine is back on gold, and gold miners

Gold mining stocks outperformed in 2024 and are expected to do well in 2025. At this point in the rally, it's worth considering what has driven gold prices higher and why miners could still have some catching up to do.

Sponsors

Alliances

© 2025 Morningstar, Inc. All rights reserved.

Disclaimer
The data, research and opinions provided here are for information purposes; are not an offer to buy or sell a security; and are not warranted to be correct, complete or accurate. Morningstar, its affiliates, and third-party content providers are not responsible for any investment decisions, damages or losses resulting from, or related to, the data and analyses or their use. To the extent any content is general advice, it has been prepared for clients of Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892), without reference to your financial objectives, situation or needs. For more information refer to our Financial Services Guide. You should consider the advice in light of these matters and if applicable, the relevant Product Disclosure Statement before making any decision to invest. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your situation, contact a professional financial adviser. Articles are current as at date of publication.
This website contains information and opinions provided by third parties. Inclusion of this information does not necessarily represent Morningstar’s positions, strategies or opinions and should not be considered an endorsement by Morningstar.